| TFC |
Report |
EPS (Q2 2026) |
BEAT |
pred ~$1.12 vs. cons $1.08 |
MEDIUM |
| TFC |
Report |
Net interest income (Q2 2026) |
IN-LINE |
pred ~$3.65B vs. cons ~$3.62B |
MEDIUM |
| TFC |
Report |
Noninterest (fee) income (Q2 2026) |
BEAT |
pred ~$1.63B vs. cons ~$1.58B |
MEDIUM |
| TFC |
Guide |
FY2026 NII growth |
UNCHANGED |
guide ~+2-3% vs. cons ~+2.5% (FY2026) |
MEDIUM |
| TFC |
Guide |
FY2026 noninterest income growth |
BETTER |
guide ~+10% (HSD-to-low-double) vs. cons ~+8% (FY2026) |
MEDIUM |
| TFC |
Guide |
Q2/2H NIM |
UNCHANGED |
guide ~3.02% stable, 2H expansion vs. cons ~3.02% (Q2 2026) |
MEDIUM |
| TFC |
Guide |
FY2026 buyback program |
UNCHANGED |
guide ~$5.0B (~$1.2B Q2) vs. cons ~$5.0B (FY2026) |
MEDIUM |
| TFC |
Guide |
FY2026 expense growth / operating leverage |
UNCHANGED |
guide ~+1.75% opex vs. cons ~+1.75% (FY2026) |
LOW |
| TFC |
Guide |
ROTCE framework / CEO continuity |
UNCHANGED |
guide 14% '26 / 15% '27 / 16-18% LT vs. cons ~14% (FY2026-27) |
LOW |
| TFC |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.0% |
— |
LOW |
| TFC |
Return |
5-day cumulative residual |
-0.5% (FADE) |
A modest EPS beat is likely, but its quality is low — driven by capital-markets/trading and buyback-reduced share count rather than NII, where FY guide stays capped at +2-3% (no rate cuts, deposit-cost creep). With the stock already up ~9% since the CEO news and sitting near 52-week highs ($53.27) priced for good news, a clean-but-not-blowout print plus a continuity-only handoff narrative leaves little upside fuel. Out-period math (trading normalization, flat-to-down sequential fees guide, NIM ramp deferred to 2H/2027) caps positive revisions, so an initial pop tends to give back as estimates hold flat rather than move up. |
LOW |